Global Gene Cell Therapy CDMO Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Gene Cell Therapy CDMO market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.
This report is a detailed and comprehensive analysis for global Gene Cell Therapy CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene Cell Therapy CDMO market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gene Cell Therapy CDMO market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gene Cell Therapy CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gene Cell Therapy CDMO market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Cell Therapy CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Cell Therapy CDMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Lonza, Thermo Fisher, ACG Biologics, Charles River, Oxford Biomedica, Novartis, OBiO, GenScript, Pharmaron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene Cell Therapy CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Cell Therapy CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Cell Therapy CDMO, with revenue, gross margin, and global market share of Gene Cell Therapy CDMO from 2020 to 2025.
Chapter 3, the Gene Cell Therapy CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gene Cell Therapy CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Cell Therapy CDMO.
Chapter 13, to describe Gene Cell Therapy CDMO research findings and conclusion.
This report is a detailed and comprehensive analysis for global Gene Cell Therapy CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene Cell Therapy CDMO market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gene Cell Therapy CDMO market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gene Cell Therapy CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gene Cell Therapy CDMO market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Cell Therapy CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Cell Therapy CDMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Lonza, Thermo Fisher, ACG Biologics, Charles River, Oxford Biomedica, Novartis, OBiO, GenScript, Pharmaron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene Cell Therapy CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immune Cells
- Stem Cell
- Viral Vector
- Plasmid DNA
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Hospital
- Others
- Catalent
- Lonza
- Thermo Fisher
- ACG Biologics
- Charles River
- Oxford Biomedica
- Novartis
- OBiO
- GenScript
- Pharmaron
- Porton
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Cell Therapy CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Cell Therapy CDMO, with revenue, gross margin, and global market share of Gene Cell Therapy CDMO from 2020 to 2025.
Chapter 3, the Gene Cell Therapy CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gene Cell Therapy CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Cell Therapy CDMO.
Chapter 13, to describe Gene Cell Therapy CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene Cell Therapy CDMO by Type
1.3.1 Overview: Global Gene Cell Therapy CDMO Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Gene Cell Therapy CDMO Consumption Value Market Share by Type in 2024
1.3.3 Immune Cells
1.3.4 Stem Cell
1.3.5 Viral Vector
1.3.6 Plasmid DNA
1.4 Global Gene Cell Therapy CDMO Market by Application
1.4.1 Overview: Global Gene Cell Therapy CDMO Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical and Biotechnology Companies
1.4.3 Research and Academic Institutions
1.4.4 Hospital
1.4.5 Others
1.5 Global Gene Cell Therapy CDMO Market Size & Forecast
1.6 Global Gene Cell Therapy CDMO Market Size and Forecast by Region
1.6.1 Global Gene Cell Therapy CDMO Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Gene Cell Therapy CDMO Market Size by Region, (2020-2031)
1.6.3 North America Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
1.6.4 Europe Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
1.6.6 South America Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Catalent
2.1.1 Catalent Details
2.1.2 Catalent Major Business
2.1.3 Catalent Gene Cell Therapy CDMO Product and Solutions
2.1.4 Catalent Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Catalent Recent Developments and Future Plans
2.2 Lonza
2.2.1 Lonza Details
2.2.2 Lonza Major Business
2.2.3 Lonza Gene Cell Therapy CDMO Product and Solutions
2.2.4 Lonza Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Lonza Recent Developments and Future Plans
2.3 Thermo Fisher
2.3.1 Thermo Fisher Details
2.3.2 Thermo Fisher Major Business
2.3.3 Thermo Fisher Gene Cell Therapy CDMO Product and Solutions
2.3.4 Thermo Fisher Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Recent Developments and Future Plans
2.4 ACG Biologics
2.4.1 ACG Biologics Details
2.4.2 ACG Biologics Major Business
2.4.3 ACG Biologics Gene Cell Therapy CDMO Product and Solutions
2.4.4 ACG Biologics Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ACG Biologics Recent Developments and Future Plans
2.5 Charles River
2.5.1 Charles River Details
2.5.2 Charles River Major Business
2.5.3 Charles River Gene Cell Therapy CDMO Product and Solutions
2.5.4 Charles River Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Charles River Recent Developments and Future Plans
2.6 Oxford Biomedica
2.6.1 Oxford Biomedica Details
2.6.2 Oxford Biomedica Major Business
2.6.3 Oxford Biomedica Gene Cell Therapy CDMO Product and Solutions
2.6.4 Oxford Biomedica Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Oxford Biomedica Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Gene Cell Therapy CDMO Product and Solutions
2.7.4 Novartis Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Novartis Recent Developments and Future Plans
2.8 OBiO
2.8.1 OBiO Details
2.8.2 OBiO Major Business
2.8.3 OBiO Gene Cell Therapy CDMO Product and Solutions
2.8.4 OBiO Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 OBiO Recent Developments and Future Plans
2.9 GenScript
2.9.1 GenScript Details
2.9.2 GenScript Major Business
2.9.3 GenScript Gene Cell Therapy CDMO Product and Solutions
2.9.4 GenScript Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 GenScript Recent Developments and Future Plans
2.10 Pharmaron
2.10.1 Pharmaron Details
2.10.2 Pharmaron Major Business
2.10.3 Pharmaron Gene Cell Therapy CDMO Product and Solutions
2.10.4 Pharmaron Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Pharmaron Recent Developments and Future Plans
2.11 Porton
2.11.1 Porton Details
2.11.2 Porton Major Business
2.11.3 Porton Gene Cell Therapy CDMO Product and Solutions
2.11.4 Porton Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Porton Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gene Cell Therapy CDMO Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Gene Cell Therapy CDMO by Company Revenue
3.2.2 Top 3 Gene Cell Therapy CDMO Players Market Share in 2024
3.2.3 Top 6 Gene Cell Therapy CDMO Players Market Share in 2024
3.3 Gene Cell Therapy CDMO Market: Overall Company Footprint Analysis
3.3.1 Gene Cell Therapy CDMO Market: Region Footprint
3.3.2 Gene Cell Therapy CDMO Market: Company Product Type Footprint
3.3.3 Gene Cell Therapy CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gene Cell Therapy CDMO Consumption Value and Market Share by Type (2020-2025)
4.2 Global Gene Cell Therapy CDMO Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2025)
5.2 Global Gene Cell Therapy CDMO Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
6.2 North America Gene Cell Therapy CDMO Market Size by Application (2020-2031)
6.3 North America Gene Cell Therapy CDMO Market Size by Country
6.3.1 North America Gene Cell Therapy CDMO Consumption Value by Country (2020-2031)
6.3.2 United States Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
6.3.3 Canada Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
6.3.4 Mexico Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
7.2 Europe Gene Cell Therapy CDMO Consumption Value by Application (2020-2031)
7.3 Europe Gene Cell Therapy CDMO Market Size by Country
7.3.1 Europe Gene Cell Therapy CDMO Consumption Value by Country (2020-2031)
7.3.2 Germany Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7.3.3 France Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7.3.5 Russia Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7.3.6 Italy Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Gene Cell Therapy CDMO Market Size by Region
8.3.1 Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Region (2020-2031)
8.3.2 China Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.3 Japan Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.4 South Korea Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.5 India Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.7 Australia Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
9.2 South America Gene Cell Therapy CDMO Consumption Value by Application (2020-2031)
9.3 South America Gene Cell Therapy CDMO Market Size by Country
9.3.1 South America Gene Cell Therapy CDMO Consumption Value by Country (2020-2031)
9.3.2 Brazil Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
9.3.3 Argentina Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Gene Cell Therapy CDMO Market Size by Country
10.3.1 Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Country (2020-2031)
10.3.2 Turkey Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
10.3.4 UAE Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Gene Cell Therapy CDMO Market Drivers
11.2 Gene Cell Therapy CDMO Market Restraints
11.3 Gene Cell Therapy CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gene Cell Therapy CDMO Industry Chain
12.2 Gene Cell Therapy CDMO Upstream Analysis
12.3 Gene Cell Therapy CDMO Midstream Analysis
12.4 Gene Cell Therapy CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene Cell Therapy CDMO by Type
1.3.1 Overview: Global Gene Cell Therapy CDMO Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Gene Cell Therapy CDMO Consumption Value Market Share by Type in 2024
1.3.3 Immune Cells
1.3.4 Stem Cell
1.3.5 Viral Vector
1.3.6 Plasmid DNA
1.4 Global Gene Cell Therapy CDMO Market by Application
1.4.1 Overview: Global Gene Cell Therapy CDMO Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical and Biotechnology Companies
1.4.3 Research and Academic Institutions
1.4.4 Hospital
1.4.5 Others
1.5 Global Gene Cell Therapy CDMO Market Size & Forecast
1.6 Global Gene Cell Therapy CDMO Market Size and Forecast by Region
1.6.1 Global Gene Cell Therapy CDMO Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Gene Cell Therapy CDMO Market Size by Region, (2020-2031)
1.6.3 North America Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
1.6.4 Europe Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
1.6.6 South America Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Gene Cell Therapy CDMO Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Catalent
2.1.1 Catalent Details
2.1.2 Catalent Major Business
2.1.3 Catalent Gene Cell Therapy CDMO Product and Solutions
2.1.4 Catalent Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Catalent Recent Developments and Future Plans
2.2 Lonza
2.2.1 Lonza Details
2.2.2 Lonza Major Business
2.2.3 Lonza Gene Cell Therapy CDMO Product and Solutions
2.2.4 Lonza Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Lonza Recent Developments and Future Plans
2.3 Thermo Fisher
2.3.1 Thermo Fisher Details
2.3.2 Thermo Fisher Major Business
2.3.3 Thermo Fisher Gene Cell Therapy CDMO Product and Solutions
2.3.4 Thermo Fisher Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Recent Developments and Future Plans
2.4 ACG Biologics
2.4.1 ACG Biologics Details
2.4.2 ACG Biologics Major Business
2.4.3 ACG Biologics Gene Cell Therapy CDMO Product and Solutions
2.4.4 ACG Biologics Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ACG Biologics Recent Developments and Future Plans
2.5 Charles River
2.5.1 Charles River Details
2.5.2 Charles River Major Business
2.5.3 Charles River Gene Cell Therapy CDMO Product and Solutions
2.5.4 Charles River Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Charles River Recent Developments and Future Plans
2.6 Oxford Biomedica
2.6.1 Oxford Biomedica Details
2.6.2 Oxford Biomedica Major Business
2.6.3 Oxford Biomedica Gene Cell Therapy CDMO Product and Solutions
2.6.4 Oxford Biomedica Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Oxford Biomedica Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Gene Cell Therapy CDMO Product and Solutions
2.7.4 Novartis Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Novartis Recent Developments and Future Plans
2.8 OBiO
2.8.1 OBiO Details
2.8.2 OBiO Major Business
2.8.3 OBiO Gene Cell Therapy CDMO Product and Solutions
2.8.4 OBiO Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 OBiO Recent Developments and Future Plans
2.9 GenScript
2.9.1 GenScript Details
2.9.2 GenScript Major Business
2.9.3 GenScript Gene Cell Therapy CDMO Product and Solutions
2.9.4 GenScript Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 GenScript Recent Developments and Future Plans
2.10 Pharmaron
2.10.1 Pharmaron Details
2.10.2 Pharmaron Major Business
2.10.3 Pharmaron Gene Cell Therapy CDMO Product and Solutions
2.10.4 Pharmaron Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Pharmaron Recent Developments and Future Plans
2.11 Porton
2.11.1 Porton Details
2.11.2 Porton Major Business
2.11.3 Porton Gene Cell Therapy CDMO Product and Solutions
2.11.4 Porton Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Porton Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gene Cell Therapy CDMO Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Gene Cell Therapy CDMO by Company Revenue
3.2.2 Top 3 Gene Cell Therapy CDMO Players Market Share in 2024
3.2.3 Top 6 Gene Cell Therapy CDMO Players Market Share in 2024
3.3 Gene Cell Therapy CDMO Market: Overall Company Footprint Analysis
3.3.1 Gene Cell Therapy CDMO Market: Region Footprint
3.3.2 Gene Cell Therapy CDMO Market: Company Product Type Footprint
3.3.3 Gene Cell Therapy CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gene Cell Therapy CDMO Consumption Value and Market Share by Type (2020-2025)
4.2 Global Gene Cell Therapy CDMO Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2025)
5.2 Global Gene Cell Therapy CDMO Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
6.2 North America Gene Cell Therapy CDMO Market Size by Application (2020-2031)
6.3 North America Gene Cell Therapy CDMO Market Size by Country
6.3.1 North America Gene Cell Therapy CDMO Consumption Value by Country (2020-2031)
6.3.2 United States Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
6.3.3 Canada Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
6.3.4 Mexico Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
7.2 Europe Gene Cell Therapy CDMO Consumption Value by Application (2020-2031)
7.3 Europe Gene Cell Therapy CDMO Market Size by Country
7.3.1 Europe Gene Cell Therapy CDMO Consumption Value by Country (2020-2031)
7.3.2 Germany Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7.3.3 France Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7.3.5 Russia Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
7.3.6 Italy Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Gene Cell Therapy CDMO Market Size by Region
8.3.1 Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Region (2020-2031)
8.3.2 China Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.3 Japan Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.4 South Korea Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.5 India Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
8.3.7 Australia Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
9.2 South America Gene Cell Therapy CDMO Consumption Value by Application (2020-2031)
9.3 South America Gene Cell Therapy CDMO Market Size by Country
9.3.1 South America Gene Cell Therapy CDMO Consumption Value by Country (2020-2031)
9.3.2 Brazil Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
9.3.3 Argentina Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Gene Cell Therapy CDMO Market Size by Country
10.3.1 Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Country (2020-2031)
10.3.2 Turkey Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
10.3.4 UAE Gene Cell Therapy CDMO Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Gene Cell Therapy CDMO Market Drivers
11.2 Gene Cell Therapy CDMO Market Restraints
11.3 Gene Cell Therapy CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gene Cell Therapy CDMO Industry Chain
12.2 Gene Cell Therapy CDMO Upstream Analysis
12.3 Gene Cell Therapy CDMO Midstream Analysis
12.4 Gene Cell Therapy CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Gene Cell Therapy CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Gene Cell Therapy CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Gene Cell Therapy CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Gene Cell Therapy CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Catalent Company Information, Head Office, and Major Competitors
Table 6. Catalent Major Business
Table 7. Catalent Gene Cell Therapy CDMO Product and Solutions
Table 8. Catalent Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Catalent Recent Developments and Future Plans
Table 10. Lonza Company Information, Head Office, and Major Competitors
Table 11. Lonza Major Business
Table 12. Lonza Gene Cell Therapy CDMO Product and Solutions
Table 13. Lonza Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Lonza Recent Developments and Future Plans
Table 15. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Major Business
Table 17. Thermo Fisher Gene Cell Therapy CDMO Product and Solutions
Table 18. Thermo Fisher Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. ACG Biologics Company Information, Head Office, and Major Competitors
Table 20. ACG Biologics Major Business
Table 21. ACG Biologics Gene Cell Therapy CDMO Product and Solutions
Table 22. ACG Biologics Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. ACG Biologics Recent Developments and Future Plans
Table 24. Charles River Company Information, Head Office, and Major Competitors
Table 25. Charles River Major Business
Table 26. Charles River Gene Cell Therapy CDMO Product and Solutions
Table 27. Charles River Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Charles River Recent Developments and Future Plans
Table 29. Oxford Biomedica Company Information, Head Office, and Major Competitors
Table 30. Oxford Biomedica Major Business
Table 31. Oxford Biomedica Gene Cell Therapy CDMO Product and Solutions
Table 32. Oxford Biomedica Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Oxford Biomedica Recent Developments and Future Plans
Table 34. Novartis Company Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Gene Cell Therapy CDMO Product and Solutions
Table 37. Novartis Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Novartis Recent Developments and Future Plans
Table 39. OBiO Company Information, Head Office, and Major Competitors
Table 40. OBiO Major Business
Table 41. OBiO Gene Cell Therapy CDMO Product and Solutions
Table 42. OBiO Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. OBiO Recent Developments and Future Plans
Table 44. GenScript Company Information, Head Office, and Major Competitors
Table 45. GenScript Major Business
Table 46. GenScript Gene Cell Therapy CDMO Product and Solutions
Table 47. GenScript Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. GenScript Recent Developments and Future Plans
Table 49. Pharmaron Company Information, Head Office, and Major Competitors
Table 50. Pharmaron Major Business
Table 51. Pharmaron Gene Cell Therapy CDMO Product and Solutions
Table 52. Pharmaron Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Pharmaron Recent Developments and Future Plans
Table 54. Porton Company Information, Head Office, and Major Competitors
Table 55. Porton Major Business
Table 56. Porton Gene Cell Therapy CDMO Product and Solutions
Table 57. Porton Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Porton Recent Developments and Future Plans
Table 59. Global Gene Cell Therapy CDMO Revenue (USD Million) by Players (2020-2025)
Table 60. Global Gene Cell Therapy CDMO Revenue Share by Players (2020-2025)
Table 61. Breakdown of Gene Cell Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in Gene Cell Therapy CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 63. Head Office of Key Gene Cell Therapy CDMO Players
Table 64. Gene Cell Therapy CDMO Market: Company Product Type Footprint
Table 65. Gene Cell Therapy CDMO Market: Company Product Application Footprint
Table 66. Gene Cell Therapy CDMO New Market Entrants and Barriers to Market Entry
Table 67. Gene Cell Therapy CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Gene Cell Therapy CDMO Consumption Value (USD Million) by Type (2020-2025)
Table 69. Global Gene Cell Therapy CDMO Consumption Value Share by Type (2020-2025)
Table 70. Global Gene Cell Therapy CDMO Consumption Value Forecast by Type (2026-2031)
Table 71. Global Gene Cell Therapy CDMO Consumption Value by Application (2020-2025)
Table 72. Global Gene Cell Therapy CDMO Consumption Value Forecast by Application (2026-2031)
Table 73. North America Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 74. North America Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 75. North America Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 76. North America Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 77. North America Gene Cell Therapy CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Gene Cell Therapy CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 80. Europe Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 81. Europe Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 82. Europe Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 83. Europe Gene Cell Therapy CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 84. Europe Gene Cell Therapy CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 85. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 86. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 87. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 90. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 91. South America Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 92. South America Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 93. South America Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 94. South America Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 95. South America Gene Cell Therapy CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 96. South America Gene Cell Therapy CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 98. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 99. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 100. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 101. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 102. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Global Key Players of Gene Cell Therapy CDMO Upstream (Raw Materials)
Table 104. Global Gene Cell Therapy CDMO Typical Customers
Table 1. Global Gene Cell Therapy CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Gene Cell Therapy CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Gene Cell Therapy CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Gene Cell Therapy CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Catalent Company Information, Head Office, and Major Competitors
Table 6. Catalent Major Business
Table 7. Catalent Gene Cell Therapy CDMO Product and Solutions
Table 8. Catalent Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Catalent Recent Developments and Future Plans
Table 10. Lonza Company Information, Head Office, and Major Competitors
Table 11. Lonza Major Business
Table 12. Lonza Gene Cell Therapy CDMO Product and Solutions
Table 13. Lonza Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Lonza Recent Developments and Future Plans
Table 15. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Major Business
Table 17. Thermo Fisher Gene Cell Therapy CDMO Product and Solutions
Table 18. Thermo Fisher Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. ACG Biologics Company Information, Head Office, and Major Competitors
Table 20. ACG Biologics Major Business
Table 21. ACG Biologics Gene Cell Therapy CDMO Product and Solutions
Table 22. ACG Biologics Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. ACG Biologics Recent Developments and Future Plans
Table 24. Charles River Company Information, Head Office, and Major Competitors
Table 25. Charles River Major Business
Table 26. Charles River Gene Cell Therapy CDMO Product and Solutions
Table 27. Charles River Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Charles River Recent Developments and Future Plans
Table 29. Oxford Biomedica Company Information, Head Office, and Major Competitors
Table 30. Oxford Biomedica Major Business
Table 31. Oxford Biomedica Gene Cell Therapy CDMO Product and Solutions
Table 32. Oxford Biomedica Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Oxford Biomedica Recent Developments and Future Plans
Table 34. Novartis Company Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Gene Cell Therapy CDMO Product and Solutions
Table 37. Novartis Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Novartis Recent Developments and Future Plans
Table 39. OBiO Company Information, Head Office, and Major Competitors
Table 40. OBiO Major Business
Table 41. OBiO Gene Cell Therapy CDMO Product and Solutions
Table 42. OBiO Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. OBiO Recent Developments and Future Plans
Table 44. GenScript Company Information, Head Office, and Major Competitors
Table 45. GenScript Major Business
Table 46. GenScript Gene Cell Therapy CDMO Product and Solutions
Table 47. GenScript Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. GenScript Recent Developments and Future Plans
Table 49. Pharmaron Company Information, Head Office, and Major Competitors
Table 50. Pharmaron Major Business
Table 51. Pharmaron Gene Cell Therapy CDMO Product and Solutions
Table 52. Pharmaron Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Pharmaron Recent Developments and Future Plans
Table 54. Porton Company Information, Head Office, and Major Competitors
Table 55. Porton Major Business
Table 56. Porton Gene Cell Therapy CDMO Product and Solutions
Table 57. Porton Gene Cell Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Porton Recent Developments and Future Plans
Table 59. Global Gene Cell Therapy CDMO Revenue (USD Million) by Players (2020-2025)
Table 60. Global Gene Cell Therapy CDMO Revenue Share by Players (2020-2025)
Table 61. Breakdown of Gene Cell Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in Gene Cell Therapy CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 63. Head Office of Key Gene Cell Therapy CDMO Players
Table 64. Gene Cell Therapy CDMO Market: Company Product Type Footprint
Table 65. Gene Cell Therapy CDMO Market: Company Product Application Footprint
Table 66. Gene Cell Therapy CDMO New Market Entrants and Barriers to Market Entry
Table 67. Gene Cell Therapy CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Gene Cell Therapy CDMO Consumption Value (USD Million) by Type (2020-2025)
Table 69. Global Gene Cell Therapy CDMO Consumption Value Share by Type (2020-2025)
Table 70. Global Gene Cell Therapy CDMO Consumption Value Forecast by Type (2026-2031)
Table 71. Global Gene Cell Therapy CDMO Consumption Value by Application (2020-2025)
Table 72. Global Gene Cell Therapy CDMO Consumption Value Forecast by Application (2026-2031)
Table 73. North America Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 74. North America Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 75. North America Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 76. North America Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 77. North America Gene Cell Therapy CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Gene Cell Therapy CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 80. Europe Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 81. Europe Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 82. Europe Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 83. Europe Gene Cell Therapy CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 84. Europe Gene Cell Therapy CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 85. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 86. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 87. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 90. Asia-Pacific Gene Cell Therapy CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 91. South America Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 92. South America Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 93. South America Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 94. South America Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 95. South America Gene Cell Therapy CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 96. South America Gene Cell Therapy CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 98. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 99. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 100. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 101. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 102. Middle East & Africa Gene Cell Therapy CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Global Key Players of Gene Cell Therapy CDMO Upstream (Raw Materials)
Table 104. Global Gene Cell Therapy CDMO Typical Customers
LIST OF FIGURES
Figure 1. Gene Cell Therapy CDMO Picture
Figure 2. Global Gene Cell Therapy CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Gene Cell Therapy CDMO Consumption Value Market Share by Type in 2024
Figure 4. Immune Cells
Figure 5. Stem Cell
Figure 6. Viral Vector
Figure 7. Plasmid DNA
Figure 8. Global Gene Cell Therapy CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Gene Cell Therapy CDMO Consumption Value Market Share by Application in 2024
Figure 10. Pharmaceutical and Biotechnology Companies Picture
Figure 11. Research and Academic Institutions Picture
Figure 12. Hospital Picture
Figure 13. Others Picture
Figure 14. Global Gene Cell Therapy CDMO Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Gene Cell Therapy CDMO Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Gene Cell Therapy CDMO Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Gene Cell Therapy CDMO Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Gene Cell Therapy CDMO Consumption Value Market Share by Region in 2024
Figure 19. North America Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Gene Cell Therapy CDMO Revenue Share by Players in 2024
Figure 26. Gene Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Gene Cell Therapy CDMO by Player Revenue in 2024
Figure 28. Top 3 Gene Cell Therapy CDMO Players Market Share in 2024
Figure 29. Top 6 Gene Cell Therapy CDMO Players Market Share in 2024
Figure 30. Global Gene Cell Therapy CDMO Consumption Value Share by Type (2020-2025)
Figure 31. Global Gene Cell Therapy CDMO Market Share Forecast by Type (2026-2031)
Figure 32. Global Gene Cell Therapy CDMO Consumption Value Share by Application (2020-2025)
Figure 33. Global Gene Cell Therapy CDMO Market Share Forecast by Application (2026-2031)
Figure 34. North America Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Gene Cell Therapy CDMO Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Gene Cell Therapy CDMO Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 44. France Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Gene Cell Therapy CDMO Consumption Value Market Share by Region (2020-2031)
Figure 51. China Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 54. India Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Gene Cell Therapy CDMO Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Gene Cell Therapy CDMO Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 68. Gene Cell Therapy CDMO Market Drivers
Figure 69. Gene Cell Therapy CDMO Market Restraints
Figure 70. Gene Cell Therapy CDMO Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Gene Cell Therapy CDMO Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Gene Cell Therapy CDMO Picture
Figure 2. Global Gene Cell Therapy CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Gene Cell Therapy CDMO Consumption Value Market Share by Type in 2024
Figure 4. Immune Cells
Figure 5. Stem Cell
Figure 6. Viral Vector
Figure 7. Plasmid DNA
Figure 8. Global Gene Cell Therapy CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Gene Cell Therapy CDMO Consumption Value Market Share by Application in 2024
Figure 10. Pharmaceutical and Biotechnology Companies Picture
Figure 11. Research and Academic Institutions Picture
Figure 12. Hospital Picture
Figure 13. Others Picture
Figure 14. Global Gene Cell Therapy CDMO Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Gene Cell Therapy CDMO Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Gene Cell Therapy CDMO Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Gene Cell Therapy CDMO Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Gene Cell Therapy CDMO Consumption Value Market Share by Region in 2024
Figure 19. North America Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Gene Cell Therapy CDMO Revenue Share by Players in 2024
Figure 26. Gene Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Gene Cell Therapy CDMO by Player Revenue in 2024
Figure 28. Top 3 Gene Cell Therapy CDMO Players Market Share in 2024
Figure 29. Top 6 Gene Cell Therapy CDMO Players Market Share in 2024
Figure 30. Global Gene Cell Therapy CDMO Consumption Value Share by Type (2020-2025)
Figure 31. Global Gene Cell Therapy CDMO Market Share Forecast by Type (2026-2031)
Figure 32. Global Gene Cell Therapy CDMO Consumption Value Share by Application (2020-2025)
Figure 33. Global Gene Cell Therapy CDMO Market Share Forecast by Application (2026-2031)
Figure 34. North America Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Gene Cell Therapy CDMO Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Gene Cell Therapy CDMO Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 44. France Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Gene Cell Therapy CDMO Consumption Value Market Share by Region (2020-2031)
Figure 51. China Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 54. India Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Gene Cell Therapy CDMO Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Gene Cell Therapy CDMO Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Gene Cell Therapy CDMO Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Gene Cell Therapy CDMO Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Gene Cell Therapy CDMO Consumption Value (2020-2031) & (USD Million)
Figure 68. Gene Cell Therapy CDMO Market Drivers
Figure 69. Gene Cell Therapy CDMO Market Restraints
Figure 70. Gene Cell Therapy CDMO Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Gene Cell Therapy CDMO Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
